Evidence map›Paper›PMID 35586453›Full record

ArticleERJ open research2022

Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD.

Linnea Jarenbäck, Sophia Frantz, Julie Weidner, Jaro Ankerst, Ulf Nihlén, Leif Bjermer, Per Wollmer, Ellen Tufvesson

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. International journal of molecular sciences · 2025
    Trial
  2. Article
  3. The Genetics behind Sulfation: Impact on Airway Remodeling.Journal of personalized medicine · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Linnea JarenbäckDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0001-5555-5773
Sophia FrantzDept of Translational Science, Clinical Physiology, Lund University, Skåne University Hospital, Malmö, Sweden.
Julie WeidnerDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0002-7140-8666
Jaro AnkerstDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Ulf NihlénDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0003-3365-5815
Leif BjermerDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Per WollmerDept of Translational Science, Clinical Physiology, Lund University, Skåne University Hospital, Malmö, Sweden.
Ellen TufvessonDept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0002-4941-332X
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single nucleotide polymorphisms (SNPs) in various genes have been shown to associate with COPD, suggesting a role in disease pathogenesis. Sulfatase modifying factor (SUMF1) is a key modifier in connective tissue remodelling, and we have shown previously that several SNPs in

Identifiers

PMID35586453
PMCPMC9108960
OpenAlexW4224280973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.